Home

With weed legalization legislation introduced to the Senate earlier this summer, savvy investors might be keen to work out the best cannabis penny...

Oncology stock Purple Biotech (NASDAQ: PPBT) is developing cancer treatments that address the tumor, along with the tumor microenvironment to...

Tiziana Life Sciences Stock has not proved shareholder-friendly thus far. Can this immunotherapy biotech company turn things around?

Upcoming earnings include Barrick Gold (NYSE: GOLD), Castle Biosciences (NASDAQ: CSTL), Honda (NYSE: HMC), Warby Parker (NYSE: WRBY) and BRC (NYSE:...

Shroom stocks, otherwise known as psychedelic stocks, present an early-stage investment opportunity that could result in mainstream health treatments.

The week ahead's IPOs previewed here are Forza X1 (NASDAQ: FRZA), Onfolio Holdings (NASDAQ: ONFO) and bioAffinity Technologies (NASDAQ: BIAF).

Check out these three companies who have a long history of paying out dividends, no matter what the economic climate is!

Cardiol Therapeutics' revolutionary new drug takes one more step towards approval with the news that the first patient has enrolled in the Phase II...